Back to Peptide Pedia
Metabolic & Weight
Limited Research

Lipo-C

LIPO-C

Lipotropic research blend.

Also known as: Lipotropic blend, MIC + L-Carnitine

Research dose rangePer-formulation (research blends)
Route studiedIntramuscular / subcutaneous
Study durationWeekly or per-session
Storage2–8 °C; protect from light

Overview

Lipo-C refers to a lipotropic research blend (commonly methionine, inositol, choline, and L-carnitine) studied in fat-metabolism models.

Key research findings

A lipotropic injection blend, classically built around MIC (methionine, inositol, choline) often combined with L-carnitine and B-vitamins. Studied as a combination approach intended to support hepatic fat processing and energy metabolism.

Mechanism of action

Combines lipotropic compounds studied for supporting fat mobilization and hepatic lipid metabolism.

Molecular information

WeightBlend (multiple components)
LengthMulti-ingredient formulation
TypeMIC / lipotropic combination blend

Typically methionine + inositol + choline (MIC), frequently with B12 and carnitine.

Research applications

  • Fat-metabolism research
  • Lipotropic-blend studies
  • Hepatic-lipid investigations

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

  1. Per-session

    Provides lipotropic cofactors intended to support fat metabolism during a regimen.

  2. Ongoing

    Outcomes depend on overall diet, activity, and the specific blend composition.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

L-Carnitine

Often already included; avoid duplicating the component.

Use caution

Fat Blaster

Overlapping lipotropic ingredients — avoid stacking duplicates.

Use caution

AOD-9604

Distinct fat-metabolism mechanism.

Compatible

Quality indicators

Verify composition

Confirm the exact MIC ratio and any added vitamins/carnitine on the label.

Characteristic color

B12-containing blends often appear pink/red; the solution should be clear and particle-free.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

  • Injection-site reactions are the most commonly reported signal for IM lipotropic blends.
  • Evidence for proprietary blends as combined weight-loss products is limited.

References & further reading

Methionine-Inositol-Choline (MIC) lipotropics (review)

Reviewhepatic fatlipotropic cofactors

Overview of the MIC lipotropic combination and the rationale behind its use in fat-metabolism research.

Topics

lipotropicblendmetabolism

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level
Limited Research

Sparse published data; largely preliminary or anecdotal.

Quick reference
Dose rangePer-formulation (research blends)
RouteIntramuscular / subcutaneous
DurationWeekly or per-session
Storage2–8 °C; protect from light
Catalogue status

This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.

Browse catalogue